RSS   Newsletter   Contact   Advertise with us

Allergy Therapeutics appoints Nick Wykeman as finance director

Staff writer | Worthing, United Kingdom | June 13, 2016
Nick WykemanJune 13, 2016, Worthing, United Kingdom - Allergy Therapeutics, a specialty pharmaceutical company, announced the appointment of Nick Wykeman to the board as finance director.
Mr. Wykeman was most recently at Skyepharma PLC until August 2015 where he was the Group Financial Controller for six years.

Prior to that, he had also worked at Quest International (a part of ICI PLC) as the Group Financial Controller (Special Projects), following six years at Deloitte & Touche.

Mr. Wykeman has a BSc (Hons) in Economics and is a qualified accountant, being a member of the Institute of Chartered Accountants of England and Wales.


 LATEST MOVES FROM The United Kingdom 


MORE INSIDE POST